Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on May 13, 2008
JNCI Journal of the National Cancer Institute 2008 100(10):752-753; doi:10.1093/jnci/djn129
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/10/752    most recent
djn129v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lusa, L.
Right arrow Articles by Gariboldi, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lusa, L.
Right arrow Articles by Gariboldi, M.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer

Lara Lusa

Bernard Peissel

Siranoush Manoukian

Edoardo Marchesi

Paolo Radice

Marco A. Pierotti

Manuela Gariboldi

Affiliations of authors: Department of Experimental Oncology (LL, EM, PR, MAP, MG) and Medical Genetics Service (BP, SM) Fondazione IRCCS (Istituti di ricerca e cura a carattere scientifico), Istituto Nazionale dei Tumori, Milano, Italy; Molecular Genetics of Cancer, IFOM Fondazione Istituto FIRC (Fondazione Italiana per la Ricerca sul Cancro) di Oncologia Molecolare, Milano, Italy (LL, EM, PR, MAP, MG)

Correspondence to: Manuela Gariboldi, PhD, Fondazione Istituti di ricerca e cura a carattere scientifico Istituto Nazionale dei Tumori, via G. Venezian 1, 20133 Milano, Italy (e-mail: manuela.gariboldi@istitutotumori.mi.it).

The first 10% of the full text of this article appears below.

We read with great interest the article by Hosey et al. (1), which proposed BRCA1-mediated transcriptional activation of ESR1 in breast cancer cell lines, thus suggesting a direct link between the BRCA1 gene and estrogen response that involves OCT-1. We assessed whether these in vitro results could be clinically confirmed in an independent cohort of primary breast cancer specimens that . . . [Full Text of this Article]

Funding


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

Response: Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer
Alison M. Hosey, Julia J. Gorski, Jennifer E. Quinn, Wen Y. Chung, Amanda Mccann, and D. Paul Harkin
J Natl Cancer Inst 2008 100: 753-754. [Extract] [Full Text] [PDF]